Holen Sie sich die Stockscreener-App
6.09
2.53%
0.15
Vorhandelsmarkt:
6.09
Schlusskurs vom Vortag:
$5.94
Offen:
$6.06
24-Stunden-Volumen:
403.26K
Relative Volume:
0.32
Marktkapitalisierung:
$460.03M
Einnahmen:
$83.57M
Nettoeinkommen (Verlust:
$-4.94M
KGV:
-87.00
EPS:
-0.07
Netto-Cashflow:
$6.97M
1W Leistung:
+12.05%
1M Leistung:
+10.93%
6M Leistung:
+119.46%
1J Leistung:
+335.00%
1-Tages-Spanne:
$6.01
$6.25
1-Wochen-Bereich:
$5.47
$6.25
52-Wochen-Spanne:
$1.36
$7.9738
Chromadex Corp Stock (CDXC) Company Profile
Firmenname
Chromadex Corp
Sektor
Branche
Telefon
310-388-6706
Adresse
10900 WILSHIRE BLVD, LOS ANGELES
Vergleichen Sie CDXC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXC
Chromadex Corp
|
6.09 | 460.03M | 83.57M | -4.94M | 6.97M | -0.07 |
|
KHC
Kraft Heinz Co
|
29.48 | 35.80B | 26.13B | 1.37B | 3.00B | 1.11 |
|
GIS
General Mills Inc
|
60.06 | 33.11B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova Co
|
81.69 | 28.11B | 12.80B | 1.01B | 927.00M | 2.91 |
|
MKC
Mccormick Co Inc
|
74.25 | 19.93B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
30.86 | 16.94B | 11.92B | 805.04M | 1.01B | 1.46 |
Chromadex Corp Stock (CDXC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-16 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2019-02-14 | Eingeleitet | B. Riley FBR | Buy |
| 2017-11-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-09-25 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-01-03 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Chromadex Corp Aktie (CDXC) Neueste Nachrichten
Barclays PLC Grows Stock Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex Co. (NASDAQ:CDXC) Short Interest Up 6.7% in December - Defense World
Short Interest in ChromaDex Co. (NASDAQ:CDXC) Grows By 6.7% - MarketBeat
StockNews.com Downgrades ChromaDex (NASDAQ:CDXC) to Buy - MarketBeat
ChromaDex (NASDAQ:CDXC) Rating Lowered to “Buy” at StockNews.com - Defense World
Jane Street Group LLC Has $167,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
ChromaDex (NASDAQ:CDXC) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
ChromaDex Corp Partners with Persona Nutrition, Expanding Global Partnership with Nestlé Health Science - Marketscreener.com
ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Business Wire
Barclays PLC Purchases 53,472 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Geode Capital Management LLC Raises Holdings in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Downgraded to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Stock Rating Lowered by StockNews.com - MarketBeat
Franklin Resources Inc. Takes Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
State Street Corp Purchases 62,692 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Shares Cross Above 200-Day Moving Average – Here’s What Happened - Defense World
ChromaDex (NASDAQ:CDXC) Share Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex - Yahoo Finance
StockNews.com Upgrades ChromaDex (NASDAQ:CDXC) to “Strong-Buy” - Defense World
Fmr LLC Takes Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Stock Rating Upgraded by StockNews.com - MarketBeat
4 Drug, Biotech Stocks Rising More Than 50% In 2024 With Room To Grow - Barchart
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow - Yahoo Finance
The Manufacturers Life Insurance Company Has $72,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to "Buy" Rating by StockNews.com - MarketBeat
ChromaDex appoints Crowe as new auditor - Investing.com
ChromaDex appoints Crowe as new auditor By Investing.com - Investing.com Canada
BNP Paribas Financial Markets Increases Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
Frank L. Jaksch, Jr. Sells 37,161 Shares of ChromaDex Co. (NASDAQ:CDXC) Stock - MarketBeat
Chromadex director Frank Jaksch sells $229,955 in stock - Investing.com
MetLife Investment Management LLC Acquires 5,115 Shares of ChromaDex Co. (NASDAQ:CDXC) - Defense World
Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 year - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Upgraded by StockNews.com to Strong-Buy Rating - Defense World
ChromaDex (CDXC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Shares Gap UpTime to Buy? - MarketBeat
ChromaDex maintains Buy rating on recent agreement By Investing.com - Investing.com Canada
ChromaDex maintains Buy rating on recent agreement - Investing.com
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category - The Bakersfield Californian
ChromaDex Named to Inc. 2024 Best in Business List for Health Products Innovation - StockTitan
ChromaDex stock soars to 52-week high, hits $7.87 By Investing.com - Investing.com Nigeria
ChromaDex stock soars to 52-week high, hits $7.87 - Investing.com
Tru Niagen’s Canadian retail footprint now includes Whole Foods in Ontario - NutraIngredients-usa.com
ChromaDex Co. (NASDAQ:CDXC) CFO Ozan Pamir Buys 2,907 Shares - MarketBeat
Chromadex CFO Pamir Ozan acquires $21,396 in company stock By Investing.com - Investing.com Australia
Chromadex CFO Pamir Ozan acquires $21,396 in company stock - Investing.com India
Insider Buying: Ozan Pamir Acquires Shares of ChromaDex Corp (CD - GuruFocus.com
Finanzdaten der Chromadex Corp-Aktie (CDXC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Chromadex Corp-Aktie (CDXC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
4.79%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):